Dr Reitsamer demonstrates primary needling. Read more about gel stent implantation in the recent article published in US Ophthalmic Review HERE.
Keywords: Glaucoma, microinvasive glaucoma surgery (MIGS), gel stent, gel implant
Dr Reitsamer demonstrates primary needling. Read more about gel stent implantation in the recent article published in US Ophthalmic Review HERE.
Keywords: Glaucoma, microinvasive glaucoma surgery (MIGS), gel stent, gel implant
Trending Topic
Endothelial cell safety is an important factor to consider when selecting early surgical treatment for glaucoma patients. It was a pleasure to speak with Dr Ticiana De Francesco (Hospital de Olhos Leiria de Andrade (HOLA) Fortaleza, Brazil) around her study on comparing the effect of cataract surgery and iStent inject, Hydrus micro-stent, or CyPass micro-stent […]
Minimally invasive glaucoma surgery (MiGS) devices have revolutionised in glaucoma management, achieving reliable IOP reduction with a favorable safety profile and quick postoperative recovery. It was a pleasure to speak with Dr Ticiana De Francesco (Hospital de Olhos Leiria de ...
World Glaucoma Week kicks off on 12 March, 2023, with the aim of raising awareness of the impact of this devastating disease. The key to preventing needless vision impairment is prompt diagnosis and treatment. However, many are unaware they have the disease ...
It is estimated that, by 2040, 111 million people around the world will have glaucoma. The Glaucoma Research Foundation is a national non-profit organization dedicated to finding a cure for glaucoma. Founded in 1978 in San Francisco, it funds glaucoma research worldwide and ...
It is estimated that, by 2040, 111 million people around the world will have glaucoma. The Glaucoma Research Foundation is a national non-profit organization dedicated to finding a cure for glaucoma. Founded in 1978 in San Francisco, it funds glaucoma research worldwide and ...
The Glaucoma Foundation is dedicated to developing a cure for glaucoma through innovative research, collaboration and education. Its goal is to eradicate blindness caused by glaucoma. The Foundation works to encourage and support basic and applied research in glaucoma with ...
We were delighted to speak with Prof. Michael Boland (Massachusetts Eye and Ear, Boston, MA, USA) about the findings of clinical trials investigating methods of assessing disease progression and emerging technologies in the future. The presentation entitled ‘Measuring Disease Progression ...
It was a pleasure to speak with Prof. Michael Boland (Massachusetts Eye and Ear, Boston, MA, USA) about methods used to measure disease progression in glaucoma. The presentation entitled ‘Measuring Disease Progression in Clinical Trials’ was presented at the 2022 American ...
We are delighted to speak with Dr Michael Greenwood (Vance Thompson Vision, Fargo, ND) about his presentation on femtosecond lasers, aberrometry, and multifocality glaucoma patients and current research in these areas. The presentation entitled ‘Femto, Aberrometry, and Multifocality in Glaucoma ...
It was a pleasure to speak with Dr Michael Greenwood (Vance Thompson Vision, Fargo, ND) to find out his thoughts on the applications, advantages and limitations of femtosecond lasers and aberrometry in cataract surgery. The presentation entitled ‘Femto, Aberrometry, and ...
We were delighted to speak with Professor Ahmad Aref (University of Illinois College of Medicine, Chicago, IL) about the COMPARE study where the efficacy of different microinvasive glaucoma surgery (MiGS) devices were compared for reducing intraocular pressure and medications in ...
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.
Or use a Social Account.
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.